Skip Navigation

This Article
Right arrow Print PDF (2158K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (173)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Bock, S. C.
Right arrow Articles by Lawn, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bock, S. C.
Right arrow Articles by Lawn, R. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1982, Vol. 10, No. 24 8113-8125
© 1982


Articles

Cloning and expression of the cDNA for human antithrom, bin III

Susan Clark Bock*, Laren L. Wion, Gordon A. Vehar and Richard M. Lawn

Genentech, Inc., 460 Point San Bruno Blvd., South San Francisco CA 94080, USA

Received September 8, 1982. Accepted November 8, 1982.

A partial cDNA clone for human antithrombin III (ATIII) was obtained by screening a cDNA library prepared from size fractionated liver RNA with a pool of eight 16–base long synthetic DNA fragments whose sequence was determined from protein sequence data. A fragment of the partial cDNA clone was used to enrich RNA for ATIII messages, and cDNA clones encoding the entire ATIII structural gene were identified. The complete nucleotide and predicted amino acid sequences of human ATIII and its 32 residue signal peptide are reported, and provide further opportunity to compare the ATIII primary structure with corresponding regions from homologous proteins, {alpha}1– antitrypsin and ovalbumin. Plasmids in which the structural genes for mature and pre–ATIII were linked to the E. coli trp promoter–operator support the synthesis of human antithrombin III and pre–antithrombin III in bacteria.


*Present address: Rockefeller University, Box 113, 1230 York Avenue, New York, NY 10021, USA


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. G. C. d. Cruz, M. A. Jairajpuri, and S. C. Bock
Disruption of a Tight Cluster Surrounding Tyrosine 131 in the Native Conformation of Antithrombin III Activates It for Factor Xa Inhibition
J. Biol. Chem., October 20, 2006; 281(42): 31668 - 31676.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
C. Kuhli, K. Jochmans, I. Scharrer, M. Luchtenberg, and L.-O. Hattenbach
Retinal Vein Occlusion Associated With Antithrombin Deficiency Secondary to a Novel G9840C Missense Mutation.
Arch Ophthalmol, August 1, 2006; 124(8): 1165 - 1169.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
Y. Tanaka, K. Ueda, T. Ozawa, I. Kitajima, S. Okamura, M. Morita, S. Yokota, and T. Imanaka
Mutation Study of Antithrombin: The Roles of Disulfide Bonds in Intracellular Accumulation and Formation of Russell Body-Like Structures
J. Biochem., March 1, 2005; 137(3): 273 - 285.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Larsson, T. Sjöblom, J. Dixelius, A. Östman, K. Ylinenjärvi, I. Björk, and L. Claesson-Welsh
Antiangiogenic Effects of Latent Antithrombin through Perturbed Cell-Matrix Interactions and Apoptosis of Endothelial Cells
Cancer Res., December 1, 2000; 60(23): 6723 - 6729.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. Larsson, P. Akerud, K. Nordling, E. Raub-Segall, L. Claesson-Welsh, and I. Bjork
A Novel Anti-angiogenic Form of Antithrombin with Retained Proteinase Binding Ability and Heparin Affinity
J. Biol. Chem., April 6, 2001; 276(15): 11996 - 12002.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.